The purpose of this study is to evaluate the effect of Panax Notoginseng Powders on Rheumatic Pain.

Inclusion Criteria:

• had a diagnosis of classic or definite RA
• without conflict to the written, informed consent signed prior to the enrollment.

Exclusion Criteria:

• uncontrolled medical problems
• organic brain syndrome
• major psychiatric disturbances
• major communicative disorders
• a history of severe noncompliance
• less than 7 years of formal education, or illiteracy
• being included in other clinical trial within the last 4 weeks
• with abnormal liver or kidney function (more than 1 time above the high normal)
• with serious cardiovascular disease
• with hematologic disease
• being in pregnancy, lactation period or under a pregnancy plan
• with severe gastrointestinal disease
• with contraindication or being allergic to the test drugs
• being under the treatment of drugs within 1 previous week, that might affect the results of the trial, such as non-steroidal anti-inflammatory drugs
• being not compatible for the trial medication, or other circumstances at the discretion of investigators
• without legal capacity or only with limited legal capacity